SCHEMBL19360179

SCHEMBL19360179

CC(C)(C)c1nc2c(c(C(C)(C)C)n1)CCN1CCCCC21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19360160 0.96 CHRNA7 (0.32) —
SCHEMBL19362452 0.78 CHRNA7 (0.30) —
SCHEMBL19360185 0.78 — —
SCHEMBL19360164 0.78 — —
SCHEMBL19360187 0.73 CHRNA7 (0.32) —
SCHEMBL19360169 0.71 HIF1A (0.33) —
SCHEMBL19360162 0.71 HIF1A (0.33) —
SCHEMBL19362228 0.71 CHRNA7 (0.31) —
SCHEMBL27114782 0.70 HRH3 (0.43) —
SCHEMBL19349868 0.68 CHRNA7 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170267679-A1 TRICYCLIC FUSED PYRIMIDINE COMPOUNDS AS INHIBITORS OF p97 COMPLEX CLEAVE BIOSCIENCES INC (US) 2017-09-21 — — US disclosed
US-20170267679-A1 TRICYCLIC FUSED PYRIMIDINE COMPOUNDS AS INHIBITORS OF p97 COMPLEX CLEAVE BIOSCIENCES INC (US) 2017-09-21 — — US disclosed
Send feedback